This topic contains a solution. Click here to go to the answer

Author Question: Nuclear fusion is the process by which A) electrons are rearranged inside an atom, releasing ... (Read 76 times)

fagboi

  • Hero Member
  • *****
  • Posts: 535
Nuclear fusion is the process by which
 
  A) electrons are rearranged inside an atom, releasing energy
  B) a number of smaller nuclei combine to form a larger nucleus with the release of energy
  C) an electron is ejected from the nucleus of an atom, releasing energy
  D) large nuclei break up into smaller nuclei with the release of energy

Question 2

Most of the Earth's carbon dioxide
 
  A) has dissolved in the oceans and is locked up in sedimentary carbonate rocks like limestone
  B) is present in the atmosphere
  C) has escaped into space
  D) has been destroyed in the atmosphere by solar radiation



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

mirabriestensky

  • Sr. Member
  • ****
  • Posts: 325
Answer to Question 1

B

Answer to Question 2

A




fagboi

  • Member
  • Posts: 535
Reply 2 on: Jul 27, 2018
Wow, this really help


ktidd

  • Member
  • Posts: 319
Reply 3 on: Yesterday
:D TYSM

 

Did you know?

The use of salicylates dates back 2,500 years to Hippocrates’s recommendation of willow bark (from which a salicylate is derived) as an aid to the pains of childbirth. However, overdosage of salicylates can harm body fluids, electrolytes, the CNS, the GI tract, the ears, the lungs, the blood, the liver, and the kidneys and cause coma or death.

Did you know?

Human kidneys will clean about 1 million gallons of blood in an average lifetime.

Did you know?

The immune system needs 9.5 hours of sleep in total darkness to recharge completely.

Did you know?

Disorders that may affect pharmacodynamics include genetic mutations, malnutrition, thyrotoxicosis, myasthenia gravis, Parkinson's disease, and certain forms of insulin-resistant diabetes mellitus.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library